论文信息 - A phase I trial and PK study of cediranib (AZD2171), an orally bioavailable pan-VEGFR inhibitor, in children with recurrent or refractory primary CNS tumors - 字舞流文

A phase I trial and PK study of cediranib (AZD2171), an orally bioavailable pan-VEGFR inhibitor, in children with recurrent or refractory primary CNS tumors

S. Vajapeyam | M. Moses | R. Packer | M. Kieran | C. Stewart | M. Fouladi | F. Fahey | S. Goldman | A. Onar-Thomas | T. Poussaint | J. Boyett | D. Turner | Shengjie Wu | L. Kun | S. Chi | R. Jakacki | A. Banerjee